On Wednesday, Shares of U.S. Bancorp (NYSE:USB), lost -1.17% to $43.01.
U.S. Bank and its associate Quintillion Limited have been recognized in Europe by HFMWeek as the best provider of trustee services, debt/loan administration and fund administration client service at the inaugural Alternative Credit Intelligence European Performance Awards in London.
Alternative Credit Intelligence, a division of global hedge fund publisher and networking service HFMWeek, assembled a judging panel for the awards comprising of leading institutional and private investors, industry experts and its own representatives. U.S. Bank was specifically recognized as:
- Best Trustee Services (Overall) – U.S. Bank Global Corporate Trust Services
- Best Debt/Loan Administration (Overall) – U.S. Bank Global Corporate Trust Services
- Best Administrator (Client Service) – Quintillion
U.S. Bank has grown its securities services businesses – corporate trust and fund administration services – considerably in Europe in recent years. In the corporate trust space, the bank entered the European market in 2010 and has since grown its client base and market share to become an established leader, maintaining the top position in the CLO market for three successive years. In the fund services space, the bank expanded in Europe through its 2013 acquisition of hedge fund administrator Quintillion. Since the acquisition, Quintillion has grown its client base and raised its assets under administration by more than 40 percent.
U.S. Bancorp, a financial services holding company, provides a range of financial services in the United States. It offers depository services, which comprise checking accounts, savings accounts, and time certificate contracts; and lending services, such as traditional credit products, in addition to credit card services, leasing, financing and import/export trade, asset-backed lending, agricultural finance, and other products.
Shares of Johnson & Johnson (NYSE:JNJ), declined -0.26% to $103.76, during its last trading session.
Johnson & Johnson (JNJ) will take part in the 34th Annual JP Morgan Health Care Conference on Monday, Jan. 11, at the Westin St. Francis in San Francisco. Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer, will represent the Company in a session planned at 2:30 p.m. (Pacific Time)/5:30 p.m. (Eastern Time).
Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
Finally, Royal Dutch Shell plc (ADR) (NYSE:RDS.A), ended its last trade with -1.12% loss, and closed at $45.97.
Royal Dutch Shell plc, published a circular and a prospectus for the recommended combination with BG Group plc, ahead of a General Meeting, planned for 10:00 (Central European Time) on Wednesday 27 January 2016 at the Circustheater, Circusstraat 4, 2586 CW The Hague, The Netherlands. In addition, BG has published a scheme document ahead of its shareholder meetings.
Royal Dutch Shell plc operates as an independent oil and gas company worldwide. It operates through Upstream and Downstream segments. The company explores for and extracts crude oil, natural gas, and natural gas liquids. It also converts natural gas to liquids to provide fuels and other products; markets and trades natural gas; extracts bitumen from mined oil sands and converts it to synthetic crude oil; and generates electricity from wind energy.
